GEORGETOWN, GUYANA – 7 AUGUST 2025 -In a brightly lit training room in Georgetown, healthcare workers from across Guyana gathered with a shared mission: to contribute towards the elimination of lymphatic filariasis (LF), a disease that has silently burdened communities for nearly two centuries. The occasion marked the launch of the 2025 Mass Drug Administration (MDA) national training, from 4 to 8 August, a collaboration between the Ministry of Health and PAHO/WHO. This was a pivotal step in Guyana’s journey towards eradicating this neglected tropical disease.
For many, the LF campaign is more than just medicine; it’s a movement of compassion, resilience, and national pride.
“In Guyana, we have five neglected infectious diseases, and our agenda is to eliminate all five of them,” said Dr. Frank Anthony, Minister of Health. “With effective interventions like the MDA, they will no longer be a public health concern. This is about restoring dignity and opportunity to our people.”
Lymphatic Filariasis, often contracted in childhood, can cause severe swelling in limbs and genitals, leading to disability and social stigma. Thanks to Guyana’s strategic use of the IDA triple drug regimen, Ivermectin, Diethylcarbamazine (DEC), and Albendazole, eight out of ten regions are now free of the disease.
A key element of Guyana’s success has been Directly Observed Therapy (DOT), where individuals take the medication in the presence of health workers. This ensures compliance and builds trust.
“Guyana is undoubtedly a leading force in public health in the Region of the Americas,” said Dr. Kim Eva Dickson, PAHO/WHO Representative. “Guyana’s commitment to eliminating lymphatic filariasis is a model for other countries. What we’re witnessing here is a country that has placed people at the heart of its health strategy.”
The campaign’s strength lies in its community-centered approach. Health workers are trained not only to administer medication but also to educate, dispel myths, and lead by example.
“We encourage our health workers to take the pills themselves,” Dr. Anthony added. “When communities see their leaders participating, it builds confidence. Every household must be reached, no one should be left behind.”
The impact of this campaign goes beyond health. By preventing disability and reducing stigma, it empowers individuals to work, care for their families, and participate fully in society.
As the training continues through 8 August, the energy in the room is palpable. Supervisors, coordinators, and field officers are not just learning, they’re preparing to make history.
“Every person who takes part in this campaign contributes to a healthier future,” said Dr. Dickson. “This is a testament to what can be achieved through collaboration, commitment, and compassion.”
Guyana’s journey toward eliminating LF is a powerful reminder that when communities unite, even the most persistent diseases can be defeated.
